APA

Ohman E. M., Roe M. T., Steg P. G., James S. K., Povsic T. J., White J., Rockhold F., Plotnikov A., Mundl H., Strony J., Sun X., Husted S., Tendera M., Montalescot G., Bahit M. C., Ardissino D., Bueno H., Claeys M. J., Nicolau J. C., Cornel J. H., Goto S., Kiss R. G., Güray Ü., Park D., Bode C., Welsh R. C. & Gibson C. M. (20180920). Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial. : Lancet (London, England).

Chicago

Ohman E Magnus, Roe Matthew T, Steg P Gabriel, James Stefan K, Povsic Thomas J, White Jennifer, Rockhold Frank, Plotnikov Alexei, Mundl Hardi, Strony John, Sun Xiang, Husted Steen, Tendera Michal, Montalescot Gilles, Bahit M Cecilia, Ardissino Diego, Bueno Héctor, Claeys Marc J, Nicolau Jose C, Cornel Jan H, Goto Shinya, Kiss Róbert Gábor, Güray Ümit, Park Duk-Woo, Bode Christoph, Welsh Robert C and Gibson C Michael. 20180920. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial. : Lancet (London, England).

Harvard

Ohman E. M., Roe M. T., Steg P. G., James S. K., Povsic T. J., White J., Rockhold F., Plotnikov A., Mundl H., Strony J., Sun X., Husted S., Tendera M., Montalescot G., Bahit M. C., Ardissino D., Bueno H., Claeys M. J., Nicolau J. C., Cornel J. H., Goto S., Kiss R. G., Güray Ü., Park D., Bode C., Welsh R. C. and Gibson C. M. (20180920). Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial. : Lancet (London, England).

MLA

Ohman E Magnus, Roe Matthew T, Steg P Gabriel, James Stefan K, Povsic Thomas J, White Jennifer, Rockhold Frank, Plotnikov Alexei, Mundl Hardi, Strony John, Sun Xiang, Husted Steen, Tendera Michal, Montalescot Gilles, Bahit M Cecilia, Ardissino Diego, Bueno Héctor, Claeys Marc J, Nicolau Jose C, Cornel Jan H, Goto Shinya, Kiss Róbert Gábor, Güray Ümit, Park Duk-Woo, Bode Christoph, Welsh Robert C and Gibson C Michael. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial. : Lancet (London, England). 20180920.